GL Pharm Tech Corp
KOSDAQ:204840
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GL Pharm Tech Corp
KOSDAQ:204840
|
KR |
|
Gap Inc
NYSE:GAP
|
US |
|
J
|
J-Long Group Ltd
NASDAQ:JL
|
HK |
|
Hometrust Bancshares Inc
NASDAQ:HTBI
|
US |
|
I
|
Imperial Logistics Ltd
F:IUC1
|
ZA |
|
Touchstar PLC
LSE:TST
|
UK |
|
R
|
REDS Real Estate Development and Services SA
ATHEX:KAMP
|
GR |
|
MEC Co Ltd
TSE:4971
|
JP |
|
US Bancorp
NYSE:USB
|
US |
|
Ackroo Inc
XTSX:AKR
|
CA |
|
Arkadia Digital Media Tbk PT
IDX:DIGI
|
ID |
|
Sterling Group Holdings Ltd
HKEX:1825
|
HK |
|
Jig-Saw Inc
TSE:3914
|
JP |
|
Blaize Holdings Inc
NASDAQ:BZAI
|
US |
|
Newcrest Mining Ltd
ASX:NCM
|
AU |
|
Cameco Corp
TSX:CCO
|
CA |
|
Hilltop Holdings Inc
NYSE:HTH
|
US |
|
Brave Bison Group PLC
LSE:BBSN
|
UK |
|
Intega Group Ltd
ASX:ITG
|
AU |
|
Triumph Group Inc
NYSE:TGI
|
US |
|
K
|
Key Alliance Group Bhd
KLSE:KGROUP
|
MY |
|
L
|
LB Semicon Co Ltd
KOSDAQ:061970
|
KR |
Bankruptcy Probability
GL Pharm Tech Corp's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
GL Pharm Tech Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
G
|
GL Pharm Tech Corp
KOSDAQ:204840
|
80.3B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
GL Pharm Tech Corp's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, GL Pharm Tech Corp has total debt of 13.1B KRW. This includes both short-term (5.9B KRW) and long-term (7.2B KRW) debt.
You can find a full breakdown on its Balance Sheet.
